Details

Autor(en) / Beteiligte

• Natarajan, Madhu K.
• Bowman, Kimberley A.
• Chisholm, Robert J.
• Adelman, Allan G.
• Isner, Jeffrey M.
• Chokshi, Saurabh K.
• Strauss, Bradley H.

Titel

Excimer laser angioplasty vs. balloon angioplasty in saphenous vein bypass grafts: Quantitative angiographic comparison of matched lesions

Ist Teil von

• Catheterization and cardiovascular diagnosis, 1996-06, Vol.38 (2), p.153-158

Ort / Verlag

New York: Wiley Subscription Services, Inc., A Wiley Company

Erscheinungsjahr

1996

Quelle

Wiley Online Library - AutoHoldings Journals

Beschreibungen/Notizen

• Technologies which ablate or debulk tissue may result in better angiographic outcomes by altering the elastic properties of the vessel wall. Accordingly, the procedural outcomes of 88 vein graft lesions treated by either excimer laser angioplasty with adjunct balloon angioplasty (PELCA + PTCA, n = 44) (Spectranetics CVX‐300, 1.4‐, 1.7‐, or 2.0‐mm catheters) or balloon angioplasty alone (PTCA, n = 44) were analyzed by quantitative angiography (Cardiac Measurement System). Lesions were individually matched for vessel position, reference diameter (RD), and minimal luminal diameter (MLD). Matching was deemed adequate as the preprocedure MLD (PELCA + PTCA, 1.14 ± 0.48 mm; PTCA, 1.20 ± 0.47 mm) and RD (PELCA + PTCA, 3.23 ± 0.56 mm; PTCA, 3.25 ± 0.57 mm) were not significantly different. There were also no significant differences between PELCA + PTCA‐ and PTCA‐treated lesions with respect to patient age, graft age, lesion length, symmetry, and plaque area. Balloon diameter at maximal inflation was 2.77 ± 0.55 mm (PELCA + PTCA group) and 2.84 ± 0.59 mm (PTCA group), P = NS. Final MLD postprocedure was 2.17 ± 0.54 mm and 2.19 ± 0.55 mm for PELCA + PTCA‐ and PTCA‐treated lesions (P = NS), respectively. Vessel stretch [(balloon diameter − MLD pre)/RD], elastic recoil [(balloon diameter − MLD post)/RD], and acute gain [(MLD post − MLD pre)/RD] were calculated and normalized for vessel size (RD). Vessel stretch (PELCA + PTCA, 0.60 ± 0.22; PTCA, 0.59 ± 0.24; P = NS), elastic recoil (PELCA + PTCA, 0.28 ± 0.18; PTCA, 0.26 ± 0.16), and acute gain (PELCA + PTCA, 0.34 ± 0.24; PTCA, 0.31 ± 0.23; P = NS) were not significantly different between the two treatment groups. In a matched population of successfully treated vein graft lesions, PELCA + PTCA did not reduce elastic recoil or improve immediate angiographic outcome, as compared with PTCA alone. © 1996 Wiley‐Liss, Inc.